Pre-Menstrual Syndrome Market Insights, Global Outlook and Forecast 2022-2028
Pre-Menstrual Syndrome Market Insights, Global Outlook and Forecast 2022-2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.
The latest research study released by Market IntelliX evaluates market size and forecasts of Pre-Menstrual Syndrome in Global, including the following market information:
Global Pre-Menstrual Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pre-Menstrual Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Analgesics (Pain Killers) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pre-Menstrual Syndrome include Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, McNeil Consumer Healthcare, MetP Pharma AG, Pherin Pharmaceuticals, Inc. and Umecrine Mood AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Pre-Menstrual Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Pre-Menstrual Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, by Type, 2021 (%)
Analgesics (Pain Killers)
Oral Contraceptive Pills (OCPs)
Gonadotropin-Releasing Hormone (GnRH)
Antidepressants
Ovarian Suppressors
Diuretics
Benzodiazepines
Global Pre-Menstrual Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Pre-Menstrual Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pre-Menstrual Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pre-Menstrual Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pre-Menstrual Syndrome revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Alva-Amco Pharmacal Cos., Inc.
Bayer, Inc.
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals, Inc.
Umecrine Mood AB
Novartis AG
GlaxoSmithKline Plc
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Pre-Menstrual Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pre-Menstrual Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pre-Menstrual Syndrome Overall Market Size
2.1 Global Pre-Menstrual Syndrome Market Size: 2021 VS 2028
2.2 Global Pre-Menstrual Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pre-Menstrual Syndrome Players in Global Market
3.2 Top Global Pre-Menstrual Syndrome Companies Ranked by Revenue
3.3 Global Pre-Menstrual Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Pre-Menstrual Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pre-Menstrual Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pre-Menstrual Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Pre-Menstrual Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Pre-Menstrual Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pre-Menstrual Syndrome Market Size Markets, 2021 & 2028
4.1.2 Analgesics (Pain Killers)
4.1.3 Oral Contraceptive Pills (OCPs)
4.1.4 Gonadotropin-Releasing Hormone (GnRH)
4.1.5 Antidepressants
4.1.6 Ovarian Suppressors
4.1.7 Diuretics
4.1.8 Benzodiazepines
4.2 By Type - Global Pre-Menstrual Syndrome Revenue & Forecasts
4.2.1 By Type - Global Pre-Menstrual Syndrome Revenue, 2017-2022
4.2.2 By Type - Global Pre-Menstrual Syndrome Revenue, 2023-2028
4.2.3 By Type - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pre-Menstrual Syndrome Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Pre-Menstrual Syndrome Revenue & Forecasts
5.2.1 By Application - Global Pre-Menstrual Syndrome Revenue, 2017-2022
5.2.2 By Application - Global Pre-Menstrual Syndrome Revenue, 2023-2028
5.2.3 By Application - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pre-Menstrual Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Pre-Menstrual Syndrome Revenue & Forecasts
6.2.1 By Region - Global Pre-Menstrual Syndrome Revenue, 2017-2022
6.2.2 By Region - Global Pre-Menstrual Syndrome Revenue, 2023-2028
6.2.3 By Region - Global Pre-Menstrual Syndrome Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pre-Menstrual Syndrome Revenue, 2017-2028
6.3.2 US Pre-Menstrual Syndrome Market Size, 2017-2028
6.3.3 Canada Pre-Menstrual Syndrome Market Size, 2017-2028
6.3.4 Mexico Pre-Menstrual Syndrome Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pre-Menstrual Syndrome Revenue, 2017-2028
6.4.2 Germany Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.3 France Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.4 U.K. Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.5 Italy Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.6 Russia Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.7 Nordic Countries Pre-Menstrual Syndrome Market Size, 2017-2028
6.4.8 Benelux Pre-Menstrual Syndrome Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pre-Menstrual Syndrome Revenue, 2017-2028
6.5.2 China Pre-Menstrual Syndrome Market Size, 2017-2028
6.5.3 Japan Pre-Menstrual Syndrome Market Size, 2017-2028
6.5.4 South Korea Pre-Menstrual Syndrome Market Size, 2017-2028
6.5.5 Southeast Asia Pre-Menstrual Syndrome Market Size, 2017-2028
6.5.6 India Pre-Menstrual Syndrome Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pre-Menstrual Syndrome Revenue, 2017-2028
6.6.2 Brazil Pre-Menstrual Syndrome Market Size, 2017-2028
6.6.3 Argentina Pre-Menstrual Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pre-Menstrual Syndrome Revenue, 2017-2028
6.7.2 Turkey Pre-Menstrual Syndrome Market Size, 2017-2028
6.7.3 Israel Pre-Menstrual Syndrome Market Size, 2017-2028
6.7.4 Saudi Arabia Pre-Menstrual Syndrome Market Size, 2017-2028
6.7.5 UAE Pre-Menstrual Syndrome Market Size, 2017-2028
7 Players Profiles
7.1 Alva-Amco Pharmacal Cos., Inc.
7.1.1 Alva-Amco Pharmacal Cos., Inc. Corporate Summary
7.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview
7.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Major Product Offerings
7.1.4 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.1.5 Alva-Amco Pharmacal Cos., Inc. Key News
7.2 Bayer, Inc.
7.2.1 Bayer, Inc. Corporate Summary
7.2.2 Bayer, Inc. Business Overview
7.2.3 Bayer, Inc. Pre-Menstrual Syndrome Major Product Offerings
7.2.4 Bayer, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.2.5 Bayer, Inc. Key News
7.3 Chattem, Inc. (Sanofi)
7.3.1 Chattem, Inc. (Sanofi) Corporate Summary
7.3.2 Chattem, Inc. (Sanofi) Business Overview
7.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Major Product Offerings
7.3.4 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.3.5 Chattem, Inc. (Sanofi) Key News
7.4 DEKK-TEC, Inc.
7.4.1 DEKK-TEC, Inc. Corporate Summary
7.4.2 DEKK-TEC, Inc. Business Overview
7.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Major Product Offerings
7.4.4 DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.4.5 DEKK-TEC, Inc. Key News
7.5 G. R. Lane Health Products Ltd
7.5.1 G. R. Lane Health Products Ltd Corporate Summary
7.5.2 G. R. Lane Health Products Ltd Business Overview
7.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Major Product Offerings
7.5.4 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.5.5 G. R. Lane Health Products Ltd Key News
7.6 McNeil Consumer Healthcare
7.6.1 McNeil Consumer Healthcare Corporate Summary
7.6.2 McNeil Consumer Healthcare Business Overview
7.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Major Product Offerings
7.6.4 McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.6.5 McNeil Consumer Healthcare Key News
7.7 MetP Pharma AG
7.7.1 MetP Pharma AG Corporate Summary
7.7.2 MetP Pharma AG Business Overview
7.7.3 MetP Pharma AG Pre-Menstrual Syndrome Major Product Offerings
7.7.4 MetP Pharma AG Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.7.5 MetP Pharma AG Key News
7.8 Pherin Pharmaceuticals, Inc.
7.8.1 Pherin Pharmaceuticals, Inc. Corporate Summary
7.8.2 Pherin Pharmaceuticals, Inc. Business Overview
7.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Major Product Offerings
7.8.4 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.8.5 Pherin Pharmaceuticals, Inc. Key News
7.9 Umecrine Mood AB
7.9.1 Umecrine Mood AB Corporate Summary
7.9.2 Umecrine Mood AB Business Overview
7.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Major Product Offerings
7.9.4 Umecrine Mood AB Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.9.5 Umecrine Mood AB Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Pre-Menstrual Syndrome Major Product Offerings
7.10.4 Novartis AG Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.10.5 Novartis AG Key News
7.11 GlaxoSmithKline Plc
7.11.1 GlaxoSmithKline Plc Corporate Summary
7.11.2 GlaxoSmithKline Plc Business Overview
7.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Major Product Offerings
7.11.4 GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue in Global Market (2017-2022)
7.11.5 GlaxoSmithKline Plc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Pre Menstrual Syndrome Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|